Overview
- Universal and Blumhouse-Atomic Monster’s PG-13 sequel delivered an estimated $63 million domestic debut and about $109 million worldwide, including $46 million from 76 international markets.
- The film scored a B on CinemaScore and a 70% “definite recommend” on PostTrak, contrasting with roughly a 13% Rotten Tomatoes critics rating.
- Opening day reached about $29.8 million, with approximately $7.2 million from Thursday previews fueling the early surge.
- The release set multiple milestones, including the biggest post‑Thanksgiving opening, the year’s top PG-13 debut, the second-biggest 2025 horror launch, and the largest December horror opening on record.
- Unlike the first film’s day‑and‑date Peacock rollout, the sequel was theatrical‑only, and producers have said a potential third installment would hinge on continued ticket sales.